Showing results (41-50 of 57) with videos related to
Sort By:
Pageof 6
Journal of Chemotherapy (Florence, Italy)|February 28, 2022
Relationship between pathological response and molecular subtypes in locally advanced breast cancer patients receiving neoadjuvant chemotherapyEzgi Değerli, Nihan Şentürk Öztaş, Gülin Alkan, et al.Biochemical Genetics|July 2, 2016
Evaluation of Local CYP17A1 and CYP19A1 Expression Levels as Prognostic Factors in Postmenopausal Invasive Ductal Breast Cancer CasesMete Bora Tüzüner, Tülin Öztürk, Allison Pınar Eronat, et al.Genes|December 30, 2025
Bridging East and West: Real-World Clinicogenomic Landscape of Metastatic NSCLC in TürkiyeKübra Canaslan, Emre Eken, Mehmet Bilici, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 30, 2019
Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group studyH Arzu Yaşar, Hande Turna, Ece Esin, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 8, 2018
Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group studyYuksel Urun, H Arzu Yasar, Hande Turna, et al.Scientific Reports|June 16, 2026
Association between obesity and outcomes of first-line CDK4/6 inhibitor therapy in metastatic breast cancer: a multicenter real-world studyMurat Günaltılı, Murad Guliyev, Zeliha Birsin, et al.Hepato-Gastroenterology|April 28, 2015
Is perineural invasion (PN) a determinant of disease free survival in early stage colorectal cancer?Mehmet Akif Ozturk, Faysal Dane, Sila Karagoz, et al.BMC Cancer|April 2, 2020
Quality of life study of patients with unresectable locally advanced or metastatic pancreatic adenocarcinoma treated with gemcitabine+nab-paclitaxel versus gemcitabine alone: AX-PANC-SY001, a randomized phase-2 studySuayib Yalcin, Faysal Dane, Berna Oksuzoglu, et al.Current Medical Research and Opinion|May 29, 2024
Evaluation of the efficacy and safety of nivolumab in the second- or later-line treatment of patients with locally advanced/metastatic non-small cell lung cancer in Türkiye: a retrospective multicenter non-interventional registry studyNuri Karadurmus, Muhammet Ali Kaplan, Mehmet Ali Nahit Sendur, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 30, 2015
Cutaneous melanoma in Turkey: analysis of 1157 patients in the Melanoma Turkish StudyHuseyin Abali, Ismail Celik, Burcak Karaca, et al.Pageof 6